ArticleMissouri medicine
Thyroid Disease in Aging.
Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 4 citations in OpenAlex.
- DNA damage in thyroid cancer patients treated with radioactive iodine in Johannesburg, South Africa.EJNMMI reports · 2026Article
- The Clinical Implications of Ashwagandha (Nutrients · 2026Review
- Thyroid dysfunction in ageing populations.Endocrine connections · 2025Review
- Establishing the TSH reference intervals for healthy adults aged over 70 years: the Australian ASPREE cohort study.Clinical chemistry and laboratory medicine · 2025Article
- Aging-Associated Thyroid Dysfunction Contributes to Oxidative Stress and Worsened Functional Outcomes Following Traumatic Brain Injury.Antioxidants (Basel, Switzerland) · 2023Article
- Thyroid Diseases After Total Knee Replacement: A Multi-center, Propensity-score-matched Cohort Study.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid disease is common in older adults. Increasing numbers of older persons will present to physicians for care in the United States as the U.S. and world populations age. It is expected that by the year 2030 that 19-20% of the U.S. population will be over 65-years old and by 2040 that 25% of the U.S. population will be over 65-years old. It is important for clinicians to be familiar with thyroid disease in this population because of its impact on the patient's functional and cognitive state. Thyroid disease often presents in older adults with nonspecific presentations such as falls, weakness, or cognitive impairment. Thyroid abnormalities may also be detected with routine testing.
Indexed as
Identifiers
36118812PMC9462896W4296324890What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.